Adverse consequences for the human immunodeficiency virus epidemic in Spain following the new legal health framework on the illegal immigrants - Save today and pay more tomorrow;Consecuencias nefastas para la epidemia de virus de la inmunodeficiencia humana en España a raíz del nuevo marco legal sanitario sobre los inmigrantes en situación irregular: ahorra hoy y pagarás mañana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 8, 2012, Pages 431-432

  Montaner, Julio S G ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; EPIDEMIC; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLEGAL IMMIGRANT; SPAIN;

EID: 84866731581     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.08.002     Document Type: Article

References (26)

1. C.C. Carpenter, M.A. Fischl, S.M. Hammer, M.S. Hirsch, D.M. Jacobsen, and D.A. Katzenstein Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA JAMA 276 1996 146 154
2. R.M. Gulick, J.W. Mellors, D. Havlir, J.J. Eron, C. Gonzalez, and D. McMahon Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy N Engl J Med 337 1997 734
3. J.S. Montaner, P. Reiss, D. Cooper, S. Vella, M. Harris, and B. Conway A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial JAMA 279 1998 930 937
4. R.S. Hogg, M.V. O'Shaughnessy, N. Gataric, K. Craib, M.T. Schechter, and J.S.G. Montaner Decline in deaths from AIDS due to new antiretrovirals Lancet 349 1997 1294
5. R.S. Hogg, K.V. Heath, B. Yip, K.J.P. Craib, M.V. O'Shaughnessy, and M.T. Schechter Improved survival among HIV-infected individuals following initiation of antiretroviral therapy JAMA 27 1998 450 454
6. The Antiretroviral Therapy Cohort Collaboration Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Lancet 372 2008 293 299
7. R.P. Walensky, A.D. Paltiel, E. Losina, L.M. Mercincavage, B.R. Schackman, and P.E. Sax The survival benefits of AIDS treatment in the United States J Infect Dis 194 2006 11 19
8. K.M. Johnston, A. Levy, V.D. Lima, R.S. Hogg, M.W. Tyndall, and P. Gustafson Expanding access to HAART: a cost-effective approach for treating and preventing HIV AIDS 24 2010 1929 1935
9. A.S. Sturt, E.K. Dokubo, and T.T. Sint Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women Cochrane Database Syst Rev 3 2010 CD008440
10. T.C. Quinn, M.J. Wawer, N. Sewankambo, D. Serwadda, C. Li, and F. Wabwire-Mangen for the Rakai Project Study Group Viral load and heterosexual transmission of human immunodeficiency virus type 1 N Engl J Med 342 2000 921 929
11. P.L. Vernazza, B.L. Gilliam, M. Flepp, J.R. Dyer, A.C. Frank, and S.A. Fiscus Effect of antiviral treatment on the shedding of HIV-1 in semen AIDS 11 1997 1249 1254
12. S. Cu-Uvin, A.M. Caliendo, S. Reinert, A. Chang, C. Juliano-Remollino, and T.P. Flanigan Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA AIDS 14 2000 415 421
13. E. Wood, T. Kerr, B.D.L. Marshall, K. Li, R. Zhang, and R.S. Hogg Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study BMJ 338 2009 342 10.1136/bmj.b1649 b1649
14. N. Volkow, and J. Montaner Enhanced HIV testing, treatment, and support for HIV-infected substance users JAMA 303 2010 1423 1424
15. E. Wood, P. Braitstein, J.S.G. Montaner, M.T. Schechter, M.W. Tyndall, and M.V. O'Shaughnessy Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa Lancet 355 2000 2095 2100
16. J.S. Montaner, R. Hogg, E. Wood, T. Kerr, M. Tyndall, and A.R. Levy The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic Lancet 368 2006 531 536
17. V.D. Lima, K. Johnston, R.S. Hogg, A.R. Levy, P.R. Harrigan, and A. Anema Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic J Infect Dis 198 2008 59 67
18. R.M. Granich, C.F. Gilks, C. Dye, K.M. De Cock, and B.G. Williams Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Lancet 373 2008 48 57
19. R. Granich, J.G. Kahn, R. Bennett, C.B. Holmes, N. Garg, and C. Serenata Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050 PLoS ONE 7 2012 10.1371/journal.pone. e30216,0030216
20. M.S. Cohen, Y.Q. Chen, M. McCauley, T. Gamble, M.C. Hosseinipour, and N. Kumarasamy Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 2011 493 505
21. J.S.G. Montaner, V.D. Lima, R. Barrios, B. Yip, E. Wood, and T. Kerr Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study Lancet 376 2010 532 539
22. M.A. Thompson, J.A. Aberg, J.F. Hoy, A. Telenti, C. Benson, and P. Cahn Antiretroviral treatment of adult HIV infection 2012. Recommendations of the International Antiviral Society - USA Panel JAMA 308 2012 387 402
23. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services [consultado 30 Ago 2012]. Disponible en: http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
24. WHO Programmatic Update: Antiretroviral Treatment as Prevention (TasP) of HIV and TB 2012 World Health Organization Geneva
25. Fauci A. Plenary: Ending the Epidemic: Turning the Tide Together XIX International AIDS Conference July 23, 2012 2012 [consultado 30 Ago 2012]. Disponible en: http://pag.aids2012.org/flash.aspx?pid=1559
26. J.A. Perez-Molina Evaluación del impacto del nuevo marco legal sanitario sobre los inmigrantes en situación irregular en España: el caso de la infección por el virus de la inmunodeficiencia humana Enferm Infecc Microbiol Clin 30 2012 472 478